Related Experiment Video
Updated: Jul 24, 2025

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
Steffen Fuchs1,2,3,4,5,6, Clara Danßmann7, Filippos Klironomos7
1Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany. steffen.fuchs@charite.de.
Abstract:
Circular RNAs (circRNAs) are a regulatory RNA class. While cancer-driving functions have been identified for single circRNAs, how they modulate gene expression in cancer is not well understood. We investigate circRNA expression in the pediatric malignancy, neuroblastoma, through deep whole-transcriptome sequencing in 104 primary neuroblastomas covering all risk groups. We demonstrate that MYCN amplification, which defines a subset of high-risk cases, causes globally suppressed circRNA biogenesis directly dependent on the DHX9 RNA helicase. We detect similar mechanisms in shaping circRNA expression in the pediatric cancer medulloblastoma implying a general MYCN effect. Comparisons to other cancers identify 25 circRNAs that are specifically upregulated in neuroblastoma, including circARID1A. Transcribed from the ARID1A tumor suppressor gene, circARID1A promotes cell growth and survival, mediated by direct interaction with the KHSRP RNA-binding protein. Our study highlights the importance of MYCN regulating circRNAs in cancer and identifies molecular mechanisms, which explain their contribution to neuroblastoma pathogenesis.
Insights
MYCN amplification suppresses circular RNA (circRNA) production in neuroblastoma, a pediatric cancer, through DHX9 RNA helicase. This study reveals specific circRNAs, like circARID1A, driving cancer growth.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Circular RNAs (circRNAs) are regulatory molecules with identified roles in cancer.
- Mechanisms by which circRNAs modulate gene expression in cancer remain incompletely understood.
- Neuroblastoma, a pediatric malignancy, presents an opportunity to study circRNA dysregulation.
Purpose of the Study:
- To investigate circRNA expression patterns in neuroblastoma.
- To elucidate the role of MYCN amplification in circRNA biogenesis.
- To identify specific circRNAs contributing to neuroblastoma pathogenesis.
Main Methods:
- Deep whole-transcriptome sequencing of 104 primary neuroblastomas.
- Analysis of circRNA expression in relation to MYCN amplification status.
- Investigation of molecular interactions involving identified circRNAs and RNA-binding proteins.
Main Results:
- MYCN amplification globally suppresses circRNA biogenesis, dependent on DHX9 RNA helicase.
- Similar MYCN-driven circRNA suppression observed in medulloblastoma, suggesting a general mechanism.
- Identified 25 circRNAs specifically upregulated in neuroblastoma, including circARID1A.
- circARID1A promotes neuroblastoma cell growth and survival via interaction with KHSRP.
Conclusions:
- MYCN plays a critical role in regulating circRNA expression in cancer.
- DHX9 is a key mediator of MYCN's effect on circRNA biogenesis.
- circARID1A is an oncogenic circRNA in neuroblastoma, highlighting specific circRNAs as therapeutic targets.
More Related Videos
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
Abnormal Proliferation
lncRNA - Long Non-coding RNAs
MicroRNAs
Induced Pluripotent Stem Cells
Somatic...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...